Insmed CapEx decreased by 79.0% to $3.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 65.4%, from $10.07M to $3.48M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 45.4% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.49M | $1.48M | $1.14M | $1.70M | $2.90M | $582.00K | $4.69M | $3.40M | $4.88M | $2.85M | $2.15M | $4.68M | $6.78M | $3.69M | $6.77M | $10.07M | $3.48M | $2.42M | $16.59M | $3.48M |
| QoQ Change | — | -57.5% | -22.9% | +48.9% | +70.7% | -80.0% | +706.0% | -27.6% | +43.7% | -41.6% | -24.6% | +117.3% | +45.0% | -45.6% | +83.6% | +48.7% | -65.4% | -30.6% | +586.1% | -79.0% |
| YoY Change | — | — | — | — | -16.7% | -60.7% | +310.8% | +99.8% | +68.1% | +390.4% | -54.1% | +37.7% | +38.9% | +29.3% | +214.5% | +115.2% | -48.6% | -34.5% | +145.0% | -65.4% |